Curcumin is attracting considerable attention because of its numerous pharmacological antioxidant, anti-inflammatory, antiviral and antibacterial activities, as well as its therapeutic potential. Although curcumin has shown efficacy in a number of chronic health conditions, its poor bioavailability due to poor absorption, rapid metabolism and rapid systemic elimination have been shown to limit its therapeutic efficacy.
The recent development of a solid lipid curcumin formulation (Longvida® Optimized Curcumin) opens doors in terms of delivering unprecedented health benefits. The unique lipid layers protect curcumin from enzymic degradation (keeping it in its ‘free’ form), allowing transportation into the lymphatic system, thereby bypassing the liver where, still in its natural form, it is quickly metabolised. This allows curcumin to cross the blood–brain barrier. As such, our Longvida® Optimized Curcumin’s patented lipid delivery technology offers 285x greater bioavailability, 65x higher peak plasma levels, and 7x longer-lasting action than standard curcumin.
← Can you explain how the Longvida technology makes your Curcumin more bioavailable?